Edition:
United States

Profile: Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

7.88USD
4:00pm EDT
Change (% chg)

$0.23 (+3.01%)
Prev Close
$7.65
Open
$7.59
Day's High
$7.93
Day's Low
$7.51
Volume
1,489,251
Avg. Vol
1,443,385
52-wk High
$21.87
52-wk Low
$7.40

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.

Company Address

Endo International PLC

Minerva House, Simmonscourt Road
DUBLIN     00000
P: +3531.2682000

Company Web Links